Motus GI Holdings, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Pure-Vu® System
    • Overview
    • Inpatient Colonoscopy
    • High Medical Need Outpatient Colonoscopy
    • Publications
  • Healthcare Professionals
    • Clinical Benefits
    • Clinical Studies
    • Become a Pure-Vu® System Provider
  • News & Media
    • Press Releases
    • Multimedia
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Results
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact Us

Nasdaq Bell Ringing Ceremony
Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Profile
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Results
    • Overview
  • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Governance
    • Board of Directors
    • Contact the Board
    • Board Committees
    • Governance Documents
  • Investor Tools  
    • Email Alerts
    • Contacts
    • RSS News Feed
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Nov 1, 2017

Motus GI(R) Holdings, Inc. Presents Positive Clinical Data from Performance Study of the Pure-Vu(R) System at the 25th United European Gastroenterology Week

Jun 5, 2017

Motus GI™ Holdings, Inc. to Present at the 2017 Jefferies Global Healthcare Conference

May 15, 2017

Motus GI(TM) Holdings, Inc. Appoints Shervin Korangy to Board of Directors

Apr 27, 2017

Motus GI Holdings, Inc. Announces First U.S. Ambulatory Endoscopy Center Clinical Procedures Using the Pure-Vu(TM) System

Mar 22, 2017

Motus GI Appoints Samuel R. Nussbaum, M.D., to Board of Directors

Feb 28, 2017

Motus GI Holdings, Inc. Successfully Completes $30.0 Million Private Placement

Oct 18, 2016

Clinical Data Demonstrate Effectiveness of MOTUS GI(TM)'s Pure-Vu(TM) System in Achieving Adequate Bowel Prep in Poorly Prepped Colonoscopy Patients

Sep 26, 2016

MOTUS GI(TM) Receives FDA Clearance to Market the Pure-Vu(TM) System for Cleansing Poorly Prepared Colons During Colonoscopy

RSS
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    © 2021 Motus GI Holdings, Inc. All Rights Reserved.
    Privacy Policy General Terms & Conditions Disclaimer Sitemap